Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

AR polyglycine repeat doesn't cause baldness.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Androgens may block hair growth signals, targeting this could treat hair loss.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Treatment during development affects hormone balance and sexual behavior in male rats.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

DHT stops hair regrowth in mice, similar to human hair loss.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Dutasteride and finasteride affect different cell types differently.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

We need better ways to test and understand SARMs to make safer and more effective treatments.